Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Category: Uncategorized

June 10, 2026 Drug delivery / Pharma applications / Uncategorized

Combined cyclodextrins and porphyrinoid derivatives in drug delivery systems

Porphyrins are powerful photosensitive molecules with useful photophysical and redox properties, making them attractive for therapeutic use. However, they often

Continue reading

May 29, 2026 Drug delivery / Pharma applications / Uncategorized

CD-based supramolecular polymers based on host–guest interactions for cancer therapy

Cyclodextrin-based supramolecular polymers (SPCDs) have emerged as promising platforms for cancer therapy via the utilization of cyclodextrin (CD)-mediated host-guest interactions

Continue reading

May 28, 2026 CD derivatives / Drug delivery / Pharma applications / Uncategorized

PEG-β-Cyclodextrin polymer-based formulation to increase the antiangiogenic activity of rutin in vivo

Rutin (RTN) is a natural flavonoid with well-documented anti-angiogenic, antioxidant, anti-inflammatory, and anti-cancer properties. However, its therapeutic potential is limited

Continue reading

May 13, 2026 Drug delivery / Environmental / Food / Uncategorized

Structural diversity of cyclodextrin metal-organic frameworks enables their diverse applications

Cyclodextrin-based metal-organic frameworks (CD-MOFs) constitute a distinctive family of porous solids that combine the modularity of coordination networks with the

Continue reading

May 7, 2026 CD as API / Pharma applications / Uncategorized

Sugammadex vs Neostigmine: Effects on Obese Patients’ Recovery

Compared with neostigmine, sugammadex promotes faster neuromuscular recovery, but its impact on diaphragmatic function and respiratory recovery in the morbidly

Continue reading

May 6, 2026 CD derivatives / Drug delivery / Pharma applications / Uncategorized

Cyclodextrin-Amino Acid Conjugates

The scope of this review is to provide a comprehensive overview of the current synthetic methodologies for both mono- and

Continue reading

May 5, 2026 Drug delivery / Pharma applications / Uncategorized

Cyclodextrin complexation of selected tyrosine kinase inhibitors

The comprehensive physicochemical characterization and cyclodextrin complexation of four tyrosine kinase inhibitors — erlotinib, gefitinib, vandetanib, and lapatinib — were

Continue reading

March 6, 2026 Drug delivery / Pharma applications / Uncategorized

Special issue: Advanced Polymeric Biomaterials for Drug Delivery Applications

 The present Special Issue in Polymers welcomes contributions in the form of original research articles, preclinical investigations, or review articles

Continue reading

January 23, 2026 Drug delivery / Pharma applications / Uncategorized

Special issue: Bioadhesive Nanocarriers: Innovations in Drug Release and Therapeutic Effectiveness

Bioadhesive nanocarriers are a notable field for drug delivery, standing out for their ability to combine the advantages of nanotechnology

Continue reading

January 12, 2026 CD as API / CD derivatives / Drug delivery / Non-pharma applications / Pharma applications / Uncategorized

Special Issue of the 21st International Cyclodextrin Symposium

The papers from the Special Issue of the 21st International Cyclodextrin Symposium published in Carbohydrate Polymers are available (https://www.sciencedirect.com/special-issue/10BLTS8S758).  The

Continue reading

Posts pagination

«Previous Posts 1 2 3 4 5 … 17 Next Posts»

Recent Posts

  • Special Issue titled “Cyclodextrins: Properties and Applications, 4th Edition”
  • Cyclodextrins hit the golf course seven years ago — and they are still there
  • Enhancing Curcumin Efficacy Against Triple-Negative Breast Cancer
  • REVTORPYK™: A New FDA Approval for Gedatolisib/HPBCD composition
  • Reducing Cholesterol with β-CDP: Insights for NPC and AD

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (27)
  • Analysis (73)
  • CD as API (355)
  • CD derivatives (431)
  • Cosmetics and toilettry (54)
  • Diagnosis (15)
  • Drug delivery (816)
  • E-ducation (63)
  • Environmental (143)
  • Events (239)
  • Food (233)
  • Gene delivery (22)
  • Household products (6)
  • In Hungarian (4)
  • Life sciences (45)
  • Non-pharma applications (416)
  • Other industrial use (112)
  • Pharma applications (1,219)
  • Supramolecular systems (44)
  • Uncategorized (167)

Top Posts

  • Phosphorylated Beta-cyclodextrin as a New Bone-Targeting Drug Delivery System Could Change the Treatment of Osteoporosis and Other Bone Diseases
  • Cyclarity Unveils First-Ever Clinical Data Demonstrating Excretion of Oxidized Cholesterol, at American Heart Association Vascular Discovery Scientific Sessions
  • Special Issue titled "Cyclodextrins: Properties and Applications, 4th Edition"
  • Cyclodextrins hit the golf course seven years ago — and they are still there
  • Enhancing Curcumin Efficacy Against Triple-Negative Breast Cancer
  • Cyclodextrin Complexes: A New Hope Against Atherosclerosis
  • HPαCD Therapy: A Breakthrough for Krabbe Disease Treatment
  • Cyclodextrin-based electrochemical sensors for PFAS detection
  • Cyclodextrin-Capped Gold Nanoparticles - Review
  • Photodimerization of Chalcones: The Effect of Supramolecular Influences and Temperature on Reaction Selectivity

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,476 other subscribers
Loading Comments...